Spiral progression in the development of absorption enhancers based on the biology of tight junctions

Advanced Drug Delivery Reviews

Volumn 64, Issue 6, 2012, Pages 515-522

  Kondoh, Masuo ^a   Takahashi, Azusa ^a   Yagi, Kiyohito ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Absorption enhancer; Claudin; Occludin; Paracellular transport; Tight junction

Indexed keywords

ABSORPTION-ENHANCERS; CLAUDIN; OCCLUDIN; PARACELLULAR TRANSPORT; TIGHT JUNCTIONS;

BIOLOGY;

LIVING SYSTEMS STUDIES;

CEFMETAZOLE; CHITOSAN; CLAUDIN; CLAUDIN PEPTIDE; CLOSTRIDIUM TOXIN; DECANOIC ACID; EDETIC ACID; INSULIN; OCCLUDIN; OCCLUDIN PEPTIDE; OCTANOIC ACID; PENETRATION ENHANCING AGENT; POLYLYSINE; SURFACTANT; UNCLASSIFIED DRUG;

DRUG ABSORPTION; DRUG TRANSPORT; EPITHELIUM CELL; HUMAN; IN VIVO STUDY; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; REVIEW; TIGHT JUNCTION;

ADJUVANTS, PHARMACEUTIC; ANIMALS; BIOLOGICAL TRANSPORT; CLAUDINS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; EPITHELIAL CELLS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MEMBRANE PROTEINS; TIGHT JUNCTIONS;

EID: 84859715132     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2011.07.004     Document Type: Review

References (99)

1. Windsor E., Cronheim G.E. Gastro-intestinal absorption of heparin and synthetic heparinoids. Nature 1961, 190:263-264.
2. Tidball C.S. Magnesium and calcium as regulators of intestinal permeability. Am. J. Physiol. 1964, 206:243-246.
3. Cassidy M.M., Tidball C.S. Cellular mechanism of intestinal permeability alterations produced by chelation depletion. J. Cell Biol. 1967, 32:685-698.
4. Farquhar M.G., Palade G.E. Junctional complexes in various epithelia. J. Cell Biol. 1963, 17:375-412.
5. Staehelin L.A. Further observations on the fine structure of freeze-cleaved tight junctions. J. Cell Sci. 1973, 13:763-786.
6. Kachar B., Reese T.S. Evidence for the lipidic nature of tight junction strands. Nature 1982, 296:464-466.
7. Silva P.P., Kachar B. On tight-junction structure. Cell 1982, 28:441-450.
8. Aungst B.J. Intestinal permeation enhancers. J. Pharm. Sci. 2000, 89:429-442.
9. Swenson E.S., Curatolo W.J. Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv. Drug Deliv. Rev. 1992, 8:39-92.
10. Sakai K., Kutsuna T., Nishino T., Fujihara Y., Yata N. Contribution of calcium ion sequestration by polyoxyethylated nonionic surfactants to the enhanced colonic absorption of p-aminobenzoic acid. J. Pharm. Sci. 1986, 75:387-390.
11. Swenson E.S., Milisen W.B., Curatolo W. Intestinal permeability enhancement: structure-activity and structure-toxicity relationships for nonylphenoxypolyoxyethylene surfactant permeability enhancers. Pharm. Res. 1994, 11:1501-1504.
12. Swenson E.S., Milisen W.B., Curatolo W. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm. Res. 1994, 11:1132-1142.
13. Yamamoto A., Okagawa T., Kotani A., Uchiyama T., Shimura T., Tabata S., Kondo S., Muranishi S. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes. J. Pharm. Pharmacol. 1997, 49:1057-1061.
14. Sedar A.W., Forte J.G. Effects of calcium depletion on the junctional complex between oxyntic cells of gastric glands. J. Cell Biol. 1964, 22:173-188.
15. Tomita M., Shiga M., Hayashi M., Awazu S. Enhancement of colonic drug absorption by the paracellular permeation route. Pharm. Res. 1988, 5:341-346.
16. Lindmark T., Kimura Y., Artursson P. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J. Pharmacol. Exp. Ther. 1998, 284:362-369.
17. Tomita M., Hayashi M., Awazu S. Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells. J. Pharmacol. Exp. Ther. 1995, 272:739-743.
18. Schipper N.G., Olsson S., Hoogstraate J.A., deBoer A.G., Varum K.M., Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm. Res. 1997, 14:923-929.
19. McEwan G.T., Jepson M.A., Hirst B.H., Simmons N.L. Polycation-induced enhancement of epithelial paracellular permeability is independent of tight junctional characteristics. Biochim. Biophys. Acta 1993, 1148:51-60.
20. Buxton R.S., Cowin P., Franke W.W., Garrod D.R., Green K.J., King I.A., Koch P.J., Magee A.I., Rees D.A., Stanley J.R., et al. Nomenclature of the desmosomal cadherins. J. Cell Biol. 1993, 121:481-483.
21. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991, 251:1451-1455.
22. Willecke K., Hennemann H., Dahl E., Jungbluth S., Heynkes R. The diversity of connexin genes encoding gap junctional proteins. Eur. J. Cell Biol. 1991, 56:1-7.
23. Stevenson B.R., Anderson J.M., Bullivant S. The epithelial tight junction: structure, function and preliminary biochemical characterization. Mol. Cell. Biochem. 1988, 83:129-145.
24. Furuse M., Hirase T., Itoh M., Nagafuchi A., Yonemura S., Tsukita S., Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 1993, 123:1777-1788.
25. Ando-Akatsuka Y., Saitou M., Hirase T., Kishi M., Sakakibara A., Itoh M., Yonemura S., Furuse M., Tsukita S. Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues. J. Cell Biol. 1996, 133:43-47.
26. Wong V., Gumbiner B.M. A synthetic peptide corresponding to the extracellular domain of occludin perturbes the tight junction permeability barrier. J. Cell Biol. 1997, 136:399-409.
27. Tavelin S., Hashimoto K., Malkinson J., Lazorova L., Toth I., Artursson P. A new principle for tight junction modulation based on occludin peptides. Mol. Pharmacol. 2003, 64:1530-1540.
28. Everett R.S., Vanhook M.K., Barozzi N., Toth I., Johnson L.G. Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol. Pharmacol. 2006, 69:492-500.
29. Chung N.P., Mruk D., Mo M.Y., Lee W.M., Cheng C.Y. A 22-amino acid synthetic peptide corresponding to the second extracellular loop of rat occludin perturbs the blood-testis barrier and disrupts spermatogenesis reversibly in vivo. Biol. Reprod. 2001, 65:1340-1351.
30. Wong C.H., Mruk D.D., Lee W.M., Cheng C.Y. Targeted and reversible disruption of the blood-testis barrier by an FSH mutant-occludin peptide conjugate. FASEB J. 2007, 21:438-448.
31. Saitou M., Fujimoto K., Doi Y., Itoh M., Fujimoto T., Furuse M., Takano H., Noda T., Tsukita S. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J. Cell Biol. 1998, 141:397-408.
32. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., Noda T., Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol. Biol. Cell 2000, 11:4131-4142.
33. Furuse M., Fujita K., Hiiragi T., Fujimoto K., Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 1998, 141:1539-1550.
34. Furuse M., Sasaki H., Fujimoto K., Tsukita S. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J. Cell Biol. 1998, 143:391-401.
35. Furuse M., Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol. 2006, 16:181-188.
36. Mineta K., Yamamoto Y., Yamazaki Y., Tanaka H., Tada Y., Saito K., Tamura A., Igarashi M., Endo T., Takeuchi K., Tsukita S. Predicted expansion of the claudin multigene family. FEBS Lett. 2011, 585:606-612.
37. Morita K., Furuse M., Fujimoto K., Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:511-516.
38. 2+ resorption. Science 1999, 285:103-106.
39. Miyamoto T., Morita K., Takemoto D., Takeuchi K., Kitano Y., Miyakawa T., Nakayama K., Okamura Y., Sasaki H., Miyachi Y., Furuse M., Tsukita S. Tight junctions in Schwann cells of peripheral myelinated axons: a lesson from claudin-19-deficient mice. J. Cell Biol. 2005, 169:527-538.
40. Furuse M., Hata M., Furuse K., Yoshida Y., Haratake A., Sugitani Y., Noda T., Kubo A., Tsukita S. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J. Cell Biol. 2002, 156:1099-1111.
41. Tsukita S., Furuse M. Claudin-based barrier in simple and stratified cellular sheets. Curr. Opin. Cell Biol. 2002, 14:531-536.
42. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 2003, 161:653-660.
43. McClane B.A., Hanna P.C., Wnek A.P. Clostridium perfringens enterotoxin. Microb. Pathog. 1988, 4:317-323.
44. Kokai-Kun J.F., McClane B.A. Deletion analysis of the Clostridium perfringens enterotoxin. Infect. Immun. 1997, 65:1014-1022.
45. Katahira J., Inoue N., Horiguchi Y., Matsuda M., Sugimoto N. Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J. Cell Biol. 1997, 136:1239-1247.
46. Katahira J., Sugiyama H., Inoue N., Horiguchi Y., Matsuda M., Sugimoto N. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J. Biol. Chem. 1997, 272:26652-26658.
47. Sonoda N., Furuse M., Sasaki H., Yonemura S., Katahira J., Horiguchi Y., Tsukita S. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J. Cell Biol. 1999, 147:195-204.
48. Ivanov A.I., Nusrat A., Parkos C.A. Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. Mol. Biol. Cell 2004, 15:176-188.
49. Matsuda M., Kubo A., Furuse M., Tsukita S. A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movement of epithelial cells. J. Cell Sci. 2004, 117:1247-1257.
50. Kondoh M., Masuyama A., Takahashi A., Asano N., Mizuguchi H., Koizumi N., Fujii M., Hayakawa T., Horiguchi Y., Watanbe Y. A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol. Pharmacol. 2005, 67:749-756.
51. Fujita K., Katahira J., Horiguchi Y., Sonoda N., Furuse M., Tsukita S. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett. 2000, 476:258-261.
52. Kimura J., Abe H., Kamitani S., Toshima H., Fukui A., Miyake M., Kamata Y., Sugita-Konishi Y., Yamamoto S., Horiguchi Y. Clostridium perfringens enterotoxin interacts with claudins via electrostatic attraction. J. Biol. Chem. 2010, 285:401-408.
53. Chiba H., Osanai M., Murata M., Kojima T., Sawada N. Transmembrane proteins of tight junctions. Biochim. Biophys. Acta 2008, 1778:588-600.
54. Uchida H., Kondoh M., Hanada T., Takahashi A., Hamakubo T., Yagi K. A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide. Biochem. Pharmacol. 2010, 79:1437-1444.
55. Mitic L.L., Unger V.M., Anderson J.M. Expression, solubilization, and biochemical characterization of the tight junction transmembrane protein claudin-4. Protein Sci. 2003, 12:218-227.
56. Suzuki H., Kondoh M., Li X., Takahashi A., Matsuhisa K., Kakamu Y., Yamane S., Kodaka M., Isoda K., Yagi K. A toxicological evaluation of a claudin modulator, C-terminal fragment of Clostridium perfringens enterotoxin. Pharmazie 2011, 66:543-546.
57. Hanna P.C., Mietzner T.A., Schoolnik G.K., McClane B.A. Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. J. Biol. Chem. 1991, 266:11037-11043.
58. Takahashi A., Kondoh M., Masuyama A., Fujii M., Mizuguchi H., Horiguchi Y., Watanabe Y. Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4. J. Control. Release 2005, 108:56-62.
59. Ling J., Liao H., Clark R., Wong M.S., Lo D.D. Structural constraints for the binding of short peptides to claudin-4 revealed by surface plasmon resonance. J. Biol. Chem. 2008, 283:30585-30595.
60. Kakutani H., Takahashi A., Kondoh M., Saito Y., Yamaura T., Sakihama T., Hamakubo T., Yagi K. A novel screening system for claudin binder using baculoviral display. PLoS One 2011, 6:e16611.
61. Takahashi A., Komiya E., Kakutani H., Yoshida T., Fujii M., Horiguchi Y., Mizuguchi H., Tsutsumi Y., Tsunoda S., Koizumi N., Isoda K., Yagi K., Watanabe Y., Kondoh M. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis. Biochem. Pharmacol. 2008, 75:1639-1648.
62. Loisel T.P., Ansanay H., St-Onge S., Gay B., Boulanger P., Strosberg A.D., Marullo S., Bouvier M. Recovery of homogeneous and functional beta 2-adrenergic receptors from extracellular baculovirus particles. Nat. Biotechnol. 1997, 15:1300-1304.
63. Sakihama T., Masuda K., Sato T., Doi T., Kodama T., Hamakubo T. Functional reconstitution of G-protein-coupled receptor-mediated adenylyl cyclase activation by a baculoviral co-display system. J. Biotechnol. 2008, 135:28-33.
64. Sakihama T., Sato T., Iwanari H., Kitamura T., Sakaguchi S., Kodama T., Hamakubo T. A simple detection method for low-affinity membrane protein interactions by baculoviral display. PLoS One 2008, 3:e4024.
65. Van Itallie C.M., Betts L., Smedley J.G., McClane B.A., Anderson J.M. Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. J. Biol. Chem. 2008, 283:268-274.
66. Winkler L., Gehring C., Wenzel A., Muller S.L., Piehl C., Krause G., Blasig I.E., Piontek J. Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3. J. Biol. Chem. 2009, 284:18863-18872.
67. Offner S., Hekele A., Teichmann U., Weinberger S., Gross S., Kufer P., Itin C., Baeuerle P.A., Kohleisen B. Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy. Cancer Immunol. Immunother. 2005, 54:431-445.
68. Romani C., Comper F., Bandiera E., Ravaggi A., Bignotti E., Tassi R.A., Pecorelli S., Santin A.D. Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. Am. J. Obstet. Gynecol. 2009, 201:70.e1-70.e9.
69. Kato-Nakano M., Suzuki M., Kawamoto S., Furuya A., Ohta S., Nakamura K., Ando H. Characterization and evaluation of the antitumour activity of a dual-targeting monoclonal antibody against claudin-3 and claudin-4. Anticancer Res. 2010, 30:4555-4562.
70. Suzuki M., Kato-Nakano M., Kawamoto S., Furuya A., Abe Y., Misaka H., Kimoto N., Nakamura K., Ohta S., Ando H. Therapeutic antitumor efficacy of monoclonal antibody against claudin-4 for pancreatic and ovarian cancers. Cancer Sci. 2009, 100:1623-1630.
71. Kawai Y., Hamazaki Y., Fujita H., Fujita A., Sato T., Furuse M., Fujimoto T., Jetten A.M., Agata Y., Minato N. Claudin-4 induction by E-protein activity in later stages of CD4/8 double-positive thymocytes to increase positive selection efficiency. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4075-7080.
72. Fofana I., Krieger S.E., Grunert F., Glauben S., Xiao F., Fafi-Kremer S., Soulier E., Royer C., Thumann C., Mee C.J., McKeating J.A., Dragic T., Pessaux P., Stoll-Keller F., Schuster C., Thompson J., Baumert T.F. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes. Gastroenterology 2010, 139:953-964.
73. Colegio O.R., Van Itallie C., Rahner C., Anderson J.M. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am. J. Physiol. Cell Physiol. 2003, 284:C1346-C1354.
74. Colegio O.R., Van Itallie C.M., McCrea H.J., Rahner C., Anderson J.M. Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am. J. Physiol. Cell Physiol. 2002, 283:C142-C147.
75. Piehl C., Piontek J., Cording J., Wolburg H., Blasig I.E. Participation of the second extracellular loop of claudin-5 in paracellular tightening against ions, small and large molecules. Cell. Mol. Life Sci. 2010, 67:2131-2140.
76. Piontek J., Winkler L., Wolburg H., Muller S.L., Zuleger N., Piehl C., Wiesner B., Krause G., Blasig I.E. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 2008, 22:146-158.
77. Mrsny R.J., Brown G.T., Gerner-Smidt K., Buret A.G., Meddings J.B., Quan C., Koval M., Nusrat A. A key claudin extracellular loop domain is critical for epithelial barrier integrity. Am. J. Pathol. 2008, 172:905-915.
78. Muto S., Hata M., Taniguchi J., Tsuruoka S., Moriwaki K., Saitou M., Furuse K., Sasaki H., Fujimura A., Imai M., Kusano E., Tsukita S., Furuse M. Claudin-2-deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubules. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8011-8016.
79. Van Itallie C.M., Fanning A.S., Anderson J.M. Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am. J. Physiol. Renal Physiol. 2003, 285:F1078-F1084.
80. Furuse M., Furuse K., Sasaki H., Tsukita S. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J. Cell Biol. 2001, 153:263-272.
81. Hou J., Renigunta A., Yang J., Waldegger S. Claudin-4 forms paracellular chloride channel in the kidney and requires claudin-8 for tight junction localization. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18010-18015.
82. Hou J., Renigunta A., Gomes A.S., Hou M., Paul D.L., Waldegger S., Goodenough D.A. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15350-15355.
83. Gonzalez-Mariscal L., Nava P. Tight junctions, from tight intercellular seals to sophisticated protein complexes involved in drug delivery, pathogens interaction and cell proliferation. Adv. Drug Deliv. Rev. 2005, 57:811-814.
84. Majumdar S., Duvvuri S., Mitra A.K. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development. Adv. Drug Deliv. Rev. 2004, 56:1437-1452.
85. Mizuno N., Niwa T., Yotsumoto Y., Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol. Rev. 2003, 55:425-461.
86. Powell D.W. Barrier function of epithelia. Am. J. Physiol. 1981, 241:G275-G288.
87. Tiwari S.B., Amiji M.M. A review of nanocarrier-based CNS delivery systems. Curr. Drug Deliv. 2006, 3:219-232.
88. Gao B., Meier P.J. Organic anion transport across the choroid plexus. Microsc. Res. Tech. 2001, 52:60-64.
89. Koepsell H. Organic cation transporters in intestine, kidney, liver, and brain. Annu. Rev. Physiol. 1998, 60:243-266.
90. Meijer D.K., Hooiveld G.J., Schinkel A.H., van Montfoort J.E., Haas M., de Zeeuw D., Moolenaar F., Smit J.W., Meier P.J. Transport mechanisms for cationic drugs and proteins in kidney, liver and intestine: implication for drug interactions and cell-specific drug delivery. Nephrol. Dial. Transplant. 1999, 14(Suppl 4):1-3.
91. Van Aubel R.A., Masereeuw R., Russel F.G. Molecular pharmacology of renal organic anion transporters. Am. J. Physiol. Renal Physiol. 2000, 279:F216-F232.
92. Kapus A., Szaszi K. Coupling between apical and paracellular transport processes. Biochem. Cell Biol. 2006, 84:870-880.
93. Schultz S.G., Curran P.F. Coupled transport of sodium and organic solutes. Physiol. Rev. 1970, 50:637-718.
94. Van Itallie C.M., Anderson J.M. Claudins and epithelial paracellular transport. Annu. Rev. Physiol. 2006, 68:403-429.
95. + deficiency and glucose malabsorption in mouse small intestine. Gastroenterology 2011, 140:913-923.
96. Stevenson B.R., Siliciano J.D., Mooseker M.S., Goodenough D.A. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J. Cell Biol. 1986, 103:755-766.
97. Tomita M., Hayashi M., Awazu S. Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells. J. Pharm. Sci. 1996, 85:608-611.
98. Gonzalez-Mariscal L., Tapia R., Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim. Biophys. Acta 2008, 1778:729-756.
99. Nusrat A., Brown G.T., Tom J., Drake A., Bui T.T., Quan C., Mrsny R.J. Multiple protein interactions involving proposed extracellular loop domains of the tight junction protein occludin. Mol. Biol. Cell 2005, 16:1725-1734.